The trademark application CRISPR-Q was filed by Qiagen GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on February 18, 2021, and it was registered by office on May 28, 2021 without any oppositions.
It was designated 'Basic Application' for International Application 1628229 at the World Intellectual Property Organization (WIPO).
The application was filed in German (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 18, 2021.
Goods And Services
The mark was filed in class 1 with Chemical, biochemical and biotechnological diagnostic preparations for scientific use, non-medical reagents used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids and Chemical test kits for laboratory or research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids..
The mark was filed in class 5 with following description of goods:
Diagnostic preparations for medical and veterinary purposes, namely diagnostic preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely nucleic acids
Diagnostic reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes
Chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely nucleic acids
Diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely nucleic acids
Diagnostic kits containing reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes of nucleic acids for medical and veterinary medical purposes.